"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","taxid_ch1","description","data_processing","data_processing.1","data_processing.2","data_processing.3","data_processing.4","platform_id","contact_name","contact_email","contact_phone","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","cell line:ch1","cell type:ch1","molecule subtype:ch1"
"GSM4906777","PC3 cell line - exosomes","GSM4906777","Public on Feb 24 2021","Nov 13 2020","Feb 24 2021","SRA","1","PC3 cells line","Homo sapiens","cell line: PC3","cell type: human prostate cancer cell line","molecule subtype: exosomal RNA","The cell line was cultured in serum-free medium to collect the supernatant, and the extracellular vesicles (EVs) were collected by differential centrifugation following MISEV2018 guidelines.","total RNA","Use miRNeasy Serum/Plasma Kit(50) Qiagen#217184 kit for RNA extraction of samples, and follow the standard operating procedure manual provided by the kit manufacturer during extraction.The extraced total RNA is the sample.","Libraries were prepared for sequencing using standard QiagenTM miRNA library construction protocol.","9606","R19050839-PC3-JZ201910210735","The fastx_toolkit (0.0.14) software was used to dynamically remove the linker sequence fragments and low-quality fragments from the 3'end of the sequencing data.","Use seqtk (1.0-r82-dirty) and self-written R (3.x.x) scripts to perform quality control analysis on the preprocessed data.","Small RNA classification uses unitas software, and sequence alignment uses bowtie (1.0.0).","Genome_build: hg19","Supplementary_files_format_and_content: .xlsx files include microRNA expression.","GPL20795","Yutong,,Wu","garefieldyutong@gmail.com","150293690936","Third Military Medical University","高滩岩正街30号","重庆","400038","China","0","HiSeq X Ten","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16791521","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9504427","NONE","PC3","human prostate cancer cell line","exosomal RNA"
"GSM4906778","C4 cell line - exosomes","GSM4906778","Public on Feb 24 2021","Nov 13 2020","Feb 24 2021","SRA","1","C4 cells line","Homo sapiens","cell line: C4","cell type: human prostate cancer cell line","molecule subtype: exosomal RNA","The cell line was cultured in serum-free medium to collect the supernatant, and the extracellular vesicles (EVs) were collected by differential centrifugation following MISEV2018 guidelines.","total RNA","Use miRNeasy Serum/Plasma Kit(50) Qiagen#217184 kit for RNA extraction of samples, and follow the standard operating procedure manual provided by the kit manufacturer during extraction.The extraced total RNA is the sample.","Libraries were prepared for sequencing using standard QiagenTM miRNA library construction protocol.","9606","R19054532-C4-JZ201910210735","The fastx_toolkit (0.0.14) software was used to dynamically remove the linker sequence fragments and low-quality fragments from the 3'end of the sequencing data.","Use seqtk (1.0-r82-dirty) and self-written R (3.x.x) scripts to perform quality control analysis on the preprocessed data.","Small RNA classification uses unitas software, and sequence alignment uses bowtie (1.0.0).","Genome_build: hg19","Supplementary_files_format_and_content: .xlsx files include microRNA expression.","GPL20795","Yutong,,Wu","garefieldyutong@gmail.com","150293690936","Third Military Medical University","高滩岩正街30号","重庆","400038","China","0","HiSeq X Ten","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16791520","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9504428","NONE","C4","human prostate cancer cell line","exosomal RNA"
"GSM4906779","C4-2B cell line - exosomes","GSM4906779","Public on Feb 24 2021","Nov 13 2020","Feb 24 2021","SRA","1","C4-2B cell line","Homo sapiens","cell line: C4-2","cell type: human prostate cancer cell line","molecule subtype: exosomal RNA","The cell line was cultured in serum-free medium to collect the supernatant, and the extracellular vesicles (EVs) were collected by differential centrifugation following MISEV2018 guidelines.","total RNA","Use miRNeasy Serum/Plasma Kit(50) Qiagen#217184 kit for RNA extraction of samples, and follow the standard operating procedure manual provided by the kit manufacturer during extraction.The extraced total RNA is the sample.","Libraries were prepared for sequencing using standard QiagenTM miRNA library construction protocol.","9606","R19050835-C4-2B-JZ201910210735","The fastx_toolkit (0.0.14) software was used to dynamically remove the linker sequence fragments and low-quality fragments from the 3'end of the sequencing data.","Use seqtk (1.0-r82-dirty) and self-written R (3.x.x) scripts to perform quality control analysis on the preprocessed data.","Small RNA classification uses unitas software, and sequence alignment uses bowtie (1.0.0).","Genome_build: hg19","Supplementary_files_format_and_content: .xlsx files include microRNA expression.","GPL20795","Yutong,,Wu","garefieldyutong@gmail.com","150293690936","Third Military Medical University","高滩岩正街30号","重庆","400038","China","0","HiSeq X Ten","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16791519","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9504429","NONE","C4-2","human prostate cancer cell line","exosomal RNA"
